| alcohol | G62.1 | Alcoholic polyneuropathy |
| amyloidosis, familial | E85.1 | Neuropathic heredofamilial amyloidosis |
| antitetanus serum | G61.1 | Serum neuropathy |
| arsenic | G62.2 | Polyneuropathy due to other toxic agents |
| avitaminosis NEC | E56.9 | Vitamin deficiency, unspecified |
| beriberi | E51.11 | Dry beriberi |
| collagen vascular disease NEC | M35.9 | Systemic involvement of connective tissue, unspecified |
| diphtheria | A36.83 | Diphtheritic polyneuritis |
| drug or medicament | G62.0 | Drug-induced polyneuropathy |
| endocrine disease NEC | E34.9 | Endocrine disorder, unspecified |
| herpes zoster | B02.23 | Postherpetic polyneuropathy |
| hypoglycemia | E16.2 | Hypoglycemia, unspecified |
| lack of vitamin NEC | E56.9 | Vitamin deficiency, unspecified |
| lead | G62.2 | Polyneuropathy due to other toxic agents |
| leprosy | A30.9 | Leprosy, unspecified |
| Lyme disease | A69.22 | Other neurologic disorders in Lyme disease |
| metabolic disease NEC | E88.9 | Metabolic disorder, unspecified |
| microscopic polyangiitis | M31.7 | Microscopic polyangiitis |
| mumps | B26.84 | Mumps polyneuropathy |
| neoplastic disease | D49.9 | Neoplasm of unspecified behavior of unspecified site |
| nutritional deficiency NEC | E63.9 | Nutritional deficiency, unspecified |
| organophosphate compounds | G62.2 | Polyneuropathy due to other toxic agents |
| parasitic disease NEC | B89 | Unspecified parasitic disease |
| pellagra | E52 | Niacin deficiency [pellagra] |
| polyarteritis nodosa | M30.0 | Polyarteritis nodosa |
| porphyria | E80.20 | Unspecified porphyria |
| radiation | G62.82 | Radiation-induced polyneuropathy |
| sarcoidosis | D86.89 | Sarcoidosis of other sites |
| serum | G61.1 | Serum neuropathy |
| syphilis | A52.15 | Late syphilitic neuropathy |
| toxic agent NEC | G62.2 | Polyneuropathy due to other toxic agents |
| transthyretin-related familial amyloid | E85.1 | Neuropathic heredofamilial amyloidosis |
| triorthocresyl phosphate | G62.2 | Polyneuropathy due to other toxic agents |
| tuberculosis | A17.89 | Other tuberculosis of nervous system |
| uremia | N18.9 | Chronic kidney disease, unspecified |
| vitamin B12 deficiency | E53.8 | Deficiency of other specified B group vitamins |
| zoster | B02.23 | Postherpetic polyneuropathy |
| alcohol › sequelae | G65.2 | Sequelae of toxic polyneuropathy |
| arsenic › sequelae | G65.2 | Sequelae of toxic polyneuropathy |
| deficiency › B vitamins | E53.9 | Vitamin B deficiency, unspecified |
| deficiency › vitamin B6 | E53.1 | Pyridoxine deficiency |
| infectious › disease NEC | B99Not billable | Other and unspecified infectious diseases |
| infectious › mononucleosis | B27.91 | Infectious mononucleosis, unspecified with polyneuropathy |
| lead › sequelae | G65.2 | Sequelae of toxic polyneuropathy |
| organophosphate compounds › sequelae | G65.2 | Sequelae of toxic polyneuropathy |
| syphilis › congenital | A50.43 | Late congenital syphilitic polyneuropathy |
| systemic › connective tissue disorder | M35.9 | Systemic involvement of connective tissue, unspecified |
| systemic › lupus erythematosus | M32.19 | Other organ or system involvement in systemic lupus erythematosus |
| toxic agent NEC › sequelae | G65.2 | Sequelae of toxic polyneuropathy |
| triorthocresyl phosphate › sequelae | G65.2 | Sequelae of toxic polyneuropathy |
| vitamin B12 deficiency › with anemia | D51.0 | Vitamin B12 deficiency anemia due to intrinsic factor deficiency |
| vitamin B12 deficiency › with anemia › due to dietary deficiency | D51.3 | Other dietary vitamin B12 deficiency anemia |